SCHEMBL7972871

SCHEMBL7972871

Cn1nc(-c2ccc(N3CCNC3=O)cc2)c(O)c1-c1nc2cc3c(cc2[nH]1)CNC3

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TOP1 P11387 2/20 0.36
TOP2A P11388 2/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HSD17B10 Q99714 1/20 0.36
GSK3B P49841 1/20 0.33
PDGFRB P09619 1/20 0.33
FGFR1 P11362 1/20 0.33
KDR P35968 1/20 0.33
BRD4 O60885 4/20 0.33
KCNH2 Q12809 2/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
HTR1A P08908 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
DRD2 P14416 1/20 0.32
HTR1D P28221 1/20 0.32
HTR1B P28222 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10140052 0.88 TOP1 (0.36) TOP1TOP2AALDH1A1HPGDSMN1; SMN2
SCHEMBL10140048 0.87 F10 (0.38) TOP1TOP2AALDH1A1HPGDSMN1; SMN2
SCHEMBL10140047 0.86 F10 (0.40) TOP1TOP2AALDH1A1HPGDSMN1; SMN2
SCHEMBL7971008 0.86 TNKS (0.45) TOP1TOP2AALDH1A1HPGDSMN1; SMN2
SCHEMBL10140050 0.85 F10 (0.41) TOP1TOP2AALDH1A1HPGDSMN1; SMN2
SCHEMBL7966289 0.85 F10 (0.39) TOP1TOP2AALDH1A1HPGDSMN1; SMN2
SCHEMBL12758112 0.85 TOP1 (0.36) TOP1TOP2AALDH1A1HPGDSMN1; SMN2
SCHEMBL7970581 0.84 F9 (0.40) TOP1TOP2AALDH1A1HPGDSMN1; SMN2
SCHEMBL7971397 0.83 ALDH1A1 (0.39) TOP1TOP2AALDH1A1HPGDSMN1; SMN2
SCHEMBL7960814 0.83 NPC1 (0.39) TOP1TOP2AALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009143039-A2 HETEROCYCLIC COMPOUNDS AS FACTOR IXA INHIBITORS SCHERING CORPORATION (US) 2009-11-26 WO disclosed